Hospital supplies are the basic commodities required in the hospital to effectively examine, diagnose, and treat the disease or injury of patients. Patient Examination devices include Stethoscopes and Thermometers. GlobalData uses proprietary data and analytics to provide a comprehensive report on the patient examination devices devices market, including market shares of different players within Australia. Buy the latest report here.

Smarter leaders trust GlobalData

In 2021, GlobalData’s Market Model methodology determined that the leading player in the patient examination devices market in Australia was Exergen followed by Hill-Rom, 3M, Medline Industries, Cardinal Health, Owens & Minor, McKesson and Performance Health International.

A stethoscope is an auscultation device used to listen to the sounds of the inner body parts. A medical thermometer is a device that measures and indicates a human’s body temperature.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the patient examination devices devices market within Australia was expected to be over $7m in 2021.

For the latest complete market share analysis of patient examination devices device market in Australia, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.